Biochemistry, Genetics and Molecular Biology
Bovine Somatotropin
100%
Growth Hormone
100%
Insulin Resistance
85%
Skeletal Muscle
75%
Metabolic Pathway
38%
Insulin Sensitivity
37%
Lipid
26%
Cytokine
25%
Glucose Transport
22%
Homo sapiens
22%
Protein Metabolism
22%
Protein Catabolism
20%
Lipid Storage
20%
Resting Energy Expenditure
20%
Darbepoetin Alfa
20%
Energy Expenditure
20%
Bone Turnover
20%
Glucose Tolerance Test
20%
Glucose Test
20%
Tumor Necrosis Factor
20%
Lipid Metabolism
20%
ANGPTL4
20%
Erythropoietin
20%
Somatostatin
20%
Lipopolysaccharide
20%
Interleukin 6
20%
FLNA
20%
Dysplasia
20%
Lean Body Weight
14%
Insulin Signaling
13%
Lipolysis
12%
Free Fatty Acids
11%
Normal Human
10%
Gluconeogenesis
10%
Deficiency
8%
Scar Formation
8%
AMP-activated Protein Kinase
6%
Messenger RNA
6%
Joint Mobility
5%
Palmitic Acid
5%
Perfusion
5%
Lipid Oxidation
5%
Suppressor of Cytokine Signaling 1
5%
Protein Kinase B
5%
Medicine and Dentistry
Placebo
60%
Insulin Resistance
55%
Growth Hormone
40%
Skeletal Muscle
40%
Growth Hormone Deficiency
28%
Cytokine
25%
Insulin Sensitivity
24%
Prevalence
20%
Protein Degradation
20%
Twin Pregnancy
20%
Persistent Truncus Arteriosus
20%
Biological Marker
20%
Biochemical Marker
20%
Tumor Necrosis Factor
20%
Hypophysis Disease
20%
Substitution Therapy
20%
Tibia Fracture
20%
Lipid Storage
20%
Growth Hormone Release
20%
Bone Turnover
20%
Oral Glucose Tolerance Test
20%
Low Drug Dose
20%
Lipopolysaccharide
20%
Interleukin 6
20%
Lipid Metabolism
20%
Protein Metabolism
20%
Dysplasia
20%
Glucose Uptake
15%
Insulin Signaling
13%
Cell Signaling Pathway
13%
Scar Formation
12%
Acromegaly
8%
Keloid
8%
Bone Dysplasia
8%
Joint Mobility
8%
Ebstein's Anomaly
6%
Bone Injury
6%
Body Mass Index
5%
Palmitic Acid
5%
Lipid Oxidation
5%
Protein Kinase B
5%
AMP-Activated Protein Kinase
5%
Keyphrases
Growth Hormone
60%
Insulin Resistance
40%
GH Deficiency
30%
Tibia Fracture
20%
Insulin-like Growth factor-1
20%
New Biomarkers
20%
Hormone Deficiency
20%
Deposition Resistance
20%
GH Secretion
20%
IGF-I Level
20%
Overtreatment
20%
Fracture Patient
20%
Frontometaphyseal Dysplasia
20%
BIOCHEMICAL MARKERS OF BONE TURNOVER
20%
Adulthood
20%
GH Treatment
20%
Decline Rate
20%
Subject Identification
20%
Clinical Tool
20%
Hormone Use
20%
GH Replacement Therapy
20%
Puberty
20%
Placebo
20%
Pituitary Diseases
20%
Direct Oral Challenge
20%
Ectopic Lipid Accumulation
20%
Muscle Energetics
10%
Postprandial Phase
10%
Time-course Change
10%
Total Body Fat
10%
Growth Hormone Treatment
10%
Hepatic Fat
10%
Disease Control
10%
Insulin Sensitivity
8%
Keloid Scar
8%
Joint Mobility
8%
Skeletal Dysplasia
8%
Growth Hormone Deficiency
6%
Per Se
6%
Bone Remodeling Markers
6%
Fuel Supply
6%
Expression Level
6%
Bone Damage
6%
Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)
6%
Lean Body Mass
6%
Hormone Status
6%
Body Composition
6%
Clinically Significant
5%
Hormone Exposure
5%
AS160
5%
